Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim E Moors

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Parkinson'S Disease|January 8, 2024
Defining a Lewy Body: Running Up the Hill of Shifting Definitions and Evolving ConceptsTim E Moors, Dragomir Milovanovic
Metabolic Brain Disease|January 24, 2025
Acute lipid droplet accumulation induced by the inhibition of the phospholipase DDHD2 does not affect the level, solubility, or phosphoserine-129 status of α-synucleinMagdalena M Bolsinger, Tim E Moors, Lisa Brontesi, et al.
Science Advances|November 17, 2023
Increased palmitoylation improves estrogen receptor alpha-dependent hippocampal synaptic deficits in a mouse model of synucleinopathyTim E Moors, Shaomin Li, Thomas D McCaffery, et al.
Molecular Neurodegeneration|January 27, 2017
Therapeutic potential of autophagy-enhancing agents in Parkinson's diseaseTim E Moors, Jeroen J M Hoozemans, Angela Ingrassia, et al.
Molecular Neurodegeneration|November 1, 2025
C-terminus-dependent detection of lysosomal alpha-synuclein in nigral Parkinson's disease human brain neuronsMartino L Morella, Bana Al Khayrat, Tim E Moors, et al.
NPJ Parkinson'S Disease|February 29, 2024
Generation of G51D and 3D mice reveals decreased α-synuclein tetramer-monomer ratios promote Parkinson's disease phenotypesSilke Nuber, Xiaoqun Zhang, Thomas D McCaffery, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 30, 2021
Wild-type GBA1 increases the α-synuclein tetramer-monomer ratio, reduces lipid-rich aggregates, and attenuates motor and cognitive deficits in miceKelly E Glajch, Tim E Moors, Yi Chen, et al.
Molecular Neurobiology|June 28, 2018
Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson's Disease and Dementia with Lewy BodiesTim E Moors, Silvia Paciotti, Angela Ingrassia, et al.
Acta Neuropathologica Communications|June 6, 2022
Multi-platform quantitation of alpha-synuclein human brain proteoforms suggests disease-specific biochemical profiles of synucleinopathiesTim E Moors, Daniel Mona, Stefan Luehe, et al.
Acta Neuropathologica|April 6, 2024
Altered TFEB subcellular localization in nigral neurons of subjects with incidental, sporadic and GBA-related Lewy body diseasesTim E Moors, Martino L Morella, Cesc Bertran-Cobo, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Parkinson'S Disease|January 8, 2024
Defining a Lewy Body: Running Up the Hill of Shifting Definitions and Evolving ConceptsTim E Moors, Dragomir Milovanovic
Metabolic Brain Disease|January 24, 2025
Acute lipid droplet accumulation induced by the inhibition of the phospholipase DDHD2 does not affect the level, solubility, or phosphoserine-129 status of α-synucleinMagdalena M Bolsinger, Tim E Moors, Lisa Brontesi, et al.
Science Advances|November 17, 2023
Increased palmitoylation improves estrogen receptor alpha-dependent hippocampal synaptic deficits in a mouse model of synucleinopathyTim E Moors, Shaomin Li, Thomas D McCaffery, et al.
Molecular Neurodegeneration|January 27, 2017
Therapeutic potential of autophagy-enhancing agents in Parkinson's diseaseTim E Moors, Jeroen J M Hoozemans, Angela Ingrassia, et al.
Molecular Neurodegeneration|November 1, 2025
C-terminus-dependent detection of lysosomal alpha-synuclein in nigral Parkinson's disease human brain neuronsMartino L Morella, Bana Al Khayrat, Tim E Moors, et al.
NPJ Parkinson'S Disease|February 29, 2024
Generation of G51D and 3D mice reveals decreased α-synuclein tetramer-monomer ratios promote Parkinson's disease phenotypesSilke Nuber, Xiaoqun Zhang, Thomas D McCaffery, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 30, 2021
Wild-type GBA1 increases the α-synuclein tetramer-monomer ratio, reduces lipid-rich aggregates, and attenuates motor and cognitive deficits in miceKelly E Glajch, Tim E Moors, Yi Chen, et al.
Molecular Neurobiology|June 28, 2018
Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson's Disease and Dementia with Lewy BodiesTim E Moors, Silvia Paciotti, Angela Ingrassia, et al.
Acta Neuropathologica Communications|June 6, 2022
Multi-platform quantitation of alpha-synuclein human brain proteoforms suggests disease-specific biochemical profiles of synucleinopathiesTim E Moors, Daniel Mona, Stefan Luehe, et al.
Acta Neuropathologica|April 6, 2024
Altered TFEB subcellular localization in nigral neurons of subjects with incidental, sporadic and GBA-related Lewy body diseasesTim E Moors, Martino L Morella, Cesc Bertran-Cobo, et al.
Pageof 2